Scipher Medicine has acquired CrossBridge. The acquisition gives Scipher new data management and analytics capabilities to enable a more granular and real-time understanding of patients’ treatment pathways.
CrossBridge’s SaaS value-based care platform bridges gaps between patients, providers and payers, and lowers the cost of care for autoimmune disease patients.
Scipher Medicine is an immunology company that matches patients with their most effective therapy.
Terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this marks the ninth eHealth deal of 2023. There were 321 eHealth transactions reported in 2022.
